n-hydroxysuccinimide s-acetylthioacetate has been researched along with Cerebral Malaria in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crommelin, DJ; Eling, WM; Hermsen, RC; Postma, NS; Zuidema, J | 1 |
1 other study(ies) available for n-hydroxysuccinimide s-acetylthioacetate and Cerebral Malaria
Article | Year |
---|---|
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.
Topics: Animals; Humans; Injections, Intravenous; Malaria, Cerebral; Mice; Plasmodium berghei; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Succinimides; Sulfhydryl Reagents; Sulfides; Tumor Necrosis Factor-alpha | 1999 |